NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin
Estimated value
—
Awarded value
—
Suppliers
36
Lots
9
Published
22 Jul 2021
Description
National Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin. The framework will commence on 1 July 2021 for a period of 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.
Scope
- Reference
- CM/PHS/17/5550
- Commercial tool
- Standalone contract
- Contract dates
- 30 Jun 2021 to 31 Mar 2025
- Main category
- goods
- CPV classifications
- 33651520
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Security of Supply | 30% | quality | — |
| usability | 10% | quality | — |
| — | 60% | price | — |
| Usability | 10% | quality | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 36 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 9 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Lot 1 - 5% Intravenous Immunoglobulin (5% IVIg) | — | cancelled |
| 2 | Lot 2: 10% Intravenous Immunoglobulin (10% IVIg) | — | cancelled |
| 3 | Lot 3: Subcutaneous Immunoglobulin (SCIg) | — | cancelled |
| 4 | Lot 4: Facilitated Subcutaneous Immunoglobulin (fSCIg) | — | cancelled |
| 6 | Lot 6: 10% Intravenous Immunoglobulin (10% IVIg) | — | cancelled |